Oramed Pharma

$8.92 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Oramed Pharma

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Stock Analysis

last close $8.92
1-mo return -42.7%
3-mo return -60.2%
avg daily vol. 982.65T
52-week high 31.54
52-week low 5.75
market cap. $421M
forward pe -
annual div. -
roe -25.2%
ltg forecast -
dividend yield -
annual rev. $9M
inst own. 17.8%
baraka

Subscribe now for daily local and international financial news

Subscribe